Acquisition reflects steady Internationalisation gains for Diagnostics Group

German biotech R-Biopharm AG has progressed its internationalisation strategy by entering new clinical diagnostics market sectors through the acquisition of AusDiagnostics, a specialist and manufacturer of molecular biology multiplex diagnostics, extraction reagents and laboratory automation equipment.

"The existing and future molecular biology multiplex analysis platforms for syndrome testing from system supplier AusDiagnostics broadens our molecular biology expertise and perfectly complements our present clinical diagnostics portfolio," said Christian Dreher, CEO of Darmstadt located R-Biopharm. "The acquisition strengthens our position as a reliable partner for system solutions and offers our customers additional options for diagnostics."

Established in 2006, the Australian company brought its patented Multiplex Tandem PCR (MT-PCR) to market with current technology enabling simultaneous detection of up to 24 pathogens or resistance genes from a single sample.

AusDiagnostics CEO Scott Gilroy commented on the transaction as marking an exciting new chapter for the company: "Both AusDiagnostics and R-Biopharm AG share the same commitment to innovation in the biotechnology space. This acquisition strengthens AusDiagnostics and will accelerate our global presence. We've experienced tremendous, industry-leading growth over the past two years, which has been underpinned by our broad suite of innovative products, talented team and incredible, loyal customers. Joining the R-Biopharm group will allow us to further build on this and continue to deliver exceptional products and service for our Australian and international customers."

Currently employing 92 people and with offices in New Zealand, the USA and Great Britain, AusDiagnostics’ production facilities in Australia and Great Britain supply a steadily growing network of more than 25 distributors and partners around the world - from which R-Biopharm expects further synergy effects for production as well as international service and support in its clinical diagnostics line.

More information online